• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.20% Nasdaq Down 0.17%

    Acorda Therapeutics, Inc. (ACOR)

    -NasdaqGS
    30.48 Down 1.01(3.21%) May 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:31.49
    Open:31.33
    Bid:27.10 x 100
    Ask:36.00 x 2900
    1y Target Est:42.55
    Beta:1.3
    Earnings Date:Jul 29 - Aug 3 (Est.)
    Day's Range:30.43 - 31.35
    52wk Range:28.26 - 45.45
    Volume:490,148
    Avg Vol (3m):625,194
    Market Cap:1.30B
    P/E (ttm):92.08
    EPS (ttm):0.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ACORDown 3.21%1.30B
    BIIBDown 0.70%94.12B
    TEVAUp 0.23%51.59B

    Key Statistics

    Forward P/E (1 yr):32.77
    P/S (ttm):3.15
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.58
    Quarterly EPS Est (Jun-15) :0.17
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):1.42

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback